Who owns Analgin?
Analgin is owned by Sopharma (Bulgaria, BSE Sofia: SFA).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Key facts
- Current owner
- Sopharma AD reported
- Owned since
- Not recorded
- Previous owner
- None recorded
- Owner HQ
- 🇧🇬 Bulgaria, Sofia
- Origin
- 🇧🇬 Bulgaria
- Category
- Consumer health › Over-the-counter medicine › Pain relief
- Parent ticker
- BSE Sofia: SFA WSE: SPH
- Last verified
- · 1 sources
About Analgin
Analgin is the painkiller Sopharma sells in 500 mg tablets, and the company's own half-year report for 2026 names it first among the products with the largest share of its sales in Bulgaria, ahead of Famotidine, Vitamin C, Buscolysin, Allergozan and Carsil. Its marketing authorisation for the 500 mg tablet in Georgia was renewed during the period, one of the Caucasus markets where the group reported growth in sales of finished products.
Ownership timeline of Analgin
Where Analgin sits in Sopharma
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Sopharma ownership tree →
Other brands owned by Sopharma in consumer health
Latest news about Analgin
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Analgin?
The parent company of Analgin is Sopharma, a publicly listed company headquartered in Bulgaria.
Is Analgin Bulgarian?
Yes. Analgin originated in Bulgaria and its owner, Sopharma, is also headquartered in Bulgaria.
Is Analgin still owned by Sopharma?
Yes. As of 20 September 2026, Analgin is still owned by Sopharma. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sopharma Group consolidated management report for the first half of 2026 — Sopharma AD, Stock exchange filing, published 30 June 2026; retrieved 20 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.